{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:30:38Z","timestamp":1772641838196,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.leukres.2023.107035","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:18:39Z","timestamp":1675880319000},"page":"107035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-7958","authenticated-orcid":false,"given":"Gianfranco","family":"Lapietra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Zaira","family":"Limongi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Buffolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Ballar\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2023.107035_bib1","doi-asserted-by":"crossref","unstructured":"Khoury J.D., Solary E., Abla O., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022 Jul;36(7):1703\u20131719. doi: 10.1038\/s41375\u2013022-01613\u20131.","DOI":"10.1038\/s41375-022-01613-1"},{"issue":"1","key":"10.1016\/j.leukres.2023.107035_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12185-009-0471-6","article-title":"A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders","volume":"91","author":"Bee","year":"2010","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107035_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PDM.0b013e318246975e","article-title":"Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms","volume":"21","author":"Hummel","year":"2012","journal-title":"Diagn. Mol. Pathol."},{"issue":"10","key":"10.1016\/j.leukres.2023.107035_bib4","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1515\/cclm-2020-1884","article-title":"Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm","volume":"59","author":"De Bruyne","year":"2021","journal-title":"Clin. Chem. Lab Med."},{"issue":"6","key":"10.1016\/j.leukres.2023.107035_bib5","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.3324\/haematol.2013.102525","article-title":"Imatinib and ruxolitinib association: first experience in two patients","volume":"99","author":"Iurlo","year":"2014","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.leukres.2023.107035_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.77","article-title":"Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib","volume":"5","author":"Zhou","year":"2015","journal-title":"Blood Cancer J."},{"issue":"1\u20132","key":"10.1016\/j.leukres.2023.107035_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14740\/jh591","article-title":"Emergence of BCR-ABL1 chronic myeloid leukemia in a JAK2-V617F polycythemia vera","volume":"9","author":"Lorenzo","year":"2020","journal-title":"J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107035_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.2010.01458.x","article-title":"Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia","volume":"85","author":"Tefferi","year":"2010","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107035_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12185-009-0345-y","article-title":"Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001","volume":"90","author":"Nussenzveig","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107035_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107035_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/bcr294","article-title":"Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression","volume":"3","author":"Kittiniyom","year":"2001","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2023.107035_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergencyto.2006.09.015","article-title":"A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis","volume":"172","author":"Larsen","year":"2007","journal-title":"Cancer Genet. Cytogenet."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:17Z","timestamp":1758935057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":12,"alternative-id":["S0145212623000206"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107035","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107035"}}